Background: Whilst cortisol reactivity has been associated with depression and anxiety disorders, research examining cortisol reactivity with early symptoms of these conditions in males and females is limited.
Methods: At age 18, 748 males and females from Gen2 of the Raine Study were assessed for their salivary cortisol response to a psychosocial stressor using the Trier Social Stress Test (TSST). Participants later completed the Depression Anxiety Stress Scale (DASS-21) at age 20 which was used as the outcome measure in regression models.
Results: We found differences in DASS-21 across TSST responder categories in females but not males. Female reactive-responders (RR) and non-responders (NR) had increased symptoms of depression and anxiety compared to anticipatory-responders (AR). AR were associated with the lowest symptomology in females. We found limited evidence for an association between salivary cortisol summary measures (C, C, C, C, AUC and AUC) and depression/anxiety symptoms at age 20.
Conclusions: This study sheds new light on adaptive and maladaptive physiological responses to psychosocial stress in terms of depression and anxiety symptoms. These preliminary findings indicate the pattern of response to a psychosocial stressor may contribute to individual vulnerability for stress-related diseases in a sex-specific manner.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.psyneuen.2021.105605 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- The study examined the impact of different autonomous dialysis methods on patients' lives in France, focusing on work, social activities, and quality of life.
- About 33% of the participants held paid jobs, with varying levels of physical activity reported, while most patients experienced minimal issues with mobility, self-care, and overall health status.
- The findings indicate that while dialysis significantly influences professional and social aspects of life, differences between the various dialysis methods were limited.
Comorbidities of hypothyroidism.
Curr Med Res Opin
March 2025
Merck Healthcare KGaA, Darmstadt, Germany.
Hypothyroidism is a relatively common condition that may affect as many as 10% of the population worldwide when its overt and subclinical presentations are considered. Important clinical comorbidities are highly prevalent in people with hypothyroidism and diminish quality of life and functional status in a manner that is proportional to the number of comorbidities present and their severity. This article reviews the common comorbidities of hypothyroidism, as reported in the literature.
View Article and Find Full Text PDFThe relationship between negative emotions and adjustment disorder in young adults: the mediating role of rumination and insomnia.
Front Psychiatry
February 2025
Department of Child and Adolescent Psychology Division I, The Affiliated Encephalopathy Hospital of Zhengzhou University, Zhumadian, China.
Introduction: This study aimed to investigate the influence of negative emotions on adjustment disorder (AjD) in young adults, focusing on the mediating role of rumination and insomnia.
Methods: The study recruited 2015 young patients (aged 18-35) receiving treatment at the Psychosomatic Medicine Department of the Affiliated Encephalopathy Hospital of Zhengzhou University from February 2023 to March 2024. Participants completed the Depression Anxiety and Stress Scale (DASS), Ruminative Responses Scale (RRS), Insomnia Severity Scale (ISI), and Adjustment Disorder - New Module 20(ADNM-20) to assess negative emotions, rumination thinking, sleep status, and AjD.
Melatonin Aids in Treating Mood and Sleep Problems Resulting from Hormonal Therapy in Breast Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Iran J Pharm Res
January 2025
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: Hormone therapy is commonly used to treat breast cancer but can cause mood disorders and sleep disturbances, negatively impacting patients' well-being.
Objectives: This trial aimed to evaluate the effects of melatonin on sleep problems and mood changes in breast cancer patients undergoing hormone therapy.
Methods: The study was conducted at Omid Hospital in Isfahan, Iran, using a randomized, double-blinded, placebo-controlled design.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!